🇺🇸 FDA

Company profile · Sponsor

Spyre

Spyre Therapeutics

SYRE · NYSE pharma WALTHAM, MA, USA
Pipeline
8
Drugs
0
Patents
0

Quick answer

Spyre (SYRE) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker SYRE
Exchange NYSE
Company type pharma
Headquarters WALTHAM, MA, USA
SEC CIK 0001636282

Pipeline (8)

Search pipeline →

  1. SPY001

    Spyre

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  2. SPY002-072

    Spyre

    Rheumatoid Arthritis

    phase 2 small molecule active

    1 trial

  3. SPYPBO-101 Placebo to SPY072, SPY072

    Spyre

    Moderately to Severely Active Rheumatologic Disease

    phase 2 small molecule active

    1 trial

  4. SPYPBO-102, SPYPBO-101, SPY002, SPY002, SPY001-001, SPY001-001

    Spyre

    Moderately to Severely Active Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  5. SPY001-001

    Spyre

    Healthy

    phase 1 small molecule completed

    1 trial

  6. SPY002-072

    Spyre

    Healthy

    phase 1 small molecule active

    1 trial

  7. SPY002-091

    Spyre

    Healthy

    phase 1 small molecule active

    1 trial

  8. SPY003-207

    Spyre

    Healthy

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Spyre?

Spyre (SYRE) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Spyre sponsor?

We track 8 ClinicalTrials.gov-linked programs for Spyre, including SPY001 and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Spyre company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.